| human | Q5 |
| P6178 | Dimensions author ID | 01062527112.95 |
| P269 | IdRef ID | 122941659 |
| P213 | ISNI | 0000000117596646 |
| P8189 | National Library of Israel J9U ID | 987007423952605171 |
| P1207 | NUKAT ID | n2005156883 |
| P496 | ORCID iD | 0000-0001-7667-8553 |
| P1153 | Scopus author ID | 7401797675 |
| P214 | VIAF ID | 41303223 |
| P106 | occupation | researcher | Q1650915 |
| P5008 | on focus list of Wikimedia project | WikiProject COVID-19 | Q87748614 |
| P21 | sex or gender | male | Q6581097 |
| Q96825434 | "Targeting the Feast of a Sleeping Beast": Nutrient and Mineral dependencies of an encysted Acanthamoeba castellanii |
| Q114978935 | Crocodylus porosus: a potential source of anticancer molecules |
| Q100543511 | A Decade of Progress in Deep Brain Stimulation of the Subcallosal Cingulate for the Treatment of Depression |
| Q52735933 | A novel in vivo model to study bacterial pathogenesis and screen potential therapeutic targets. |
| Q38567256 | A proposed cascade of vascular events leading to granulomatous amoebic encephalitis. |
| Q34830742 | A simple assay to screen antimicrobial compounds potentiating the activity of current antibiotics |
| Q88623930 | Acanthamoeba Keratitis: Current Status and Urgent Research Priorities |
| Q45938195 | Acanthamoeba affects the integrity of human brain microvascular endothelial cells and degrades the tight junction proteins. |
| Q41965799 | Acanthamoeba and bacteria produce antimicrobials to target their counterpart. |
| Q43016357 | Acanthamoeba can propagate on thermophilic Sulfolobus spp. |
| Q38639961 | Acanthamoeba castellanii interactions with Streptococcus pneumoniae and Streptococcus pyogenes. |
| Q42155774 | Acanthamoeba castellanii of the T4 genotype is a potential environmental host for Enterobacter aerogenes and Aeromonas hydrophila. |
| Q82909771 | Acanthamoeba castellanii: high antibody prevalence in racially and ethnically diverse populations |
| Q80375643 | Acanthamoeba induces cell-cycle arrest in host cells |
| Q40622730 | Acanthamoeba interactions with human brain microvascular endothelial cells |
| Q37964928 | Acanthamoeba is an evolutionary ancestor of macrophages: a myth or reality? |
| Q22812999 | An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment |
| Q41038625 | Anaerobic respiration: In vitro efficacy of Nitazoxanide against mitochondriate Acanthamoeba castellanii of the T4 genotype |
| Q47915197 | Anesthesia with antiamoebic effects: can anesthesia choice affect the clinical outcome of granulomatous amoebic encephalitis due to Acanthamoeba spp.? |
| Q46323131 | Animals living in polluted environments are a potential source of anti-tumor molecule(s). |
| Q37726760 | Animals living in polluted environments are potential source of antimicrobials against infectious agents |
| Q48363537 | Anti-Acanthamoebic properties of resveratrol and demethoxycurcumin |
| Q97093645 | Anti-amoebic potential of azole scaffolds and nanoparticles against pathogenic Acanthamoeba |
| Q96019414 | Antiamoebic activity of 3-aryl-6,7-dimethoxyquinazolin-4(3H)-one library against Acanthamoeba castellanii |
| Q89523440 | Antiamoebic activity of plant-based natural products and their conjugated silver nanoparticles against Acanthamoeba castellanii (ATCC 50492) |
| Q94571902 | Antiamoebic activity of synthetic tetrazoles against Acanthamoeba castellanii belonging to T4 genotype and effects of conjugation with silver nanoparticles |
| Q92122815 | Antibacterial Activities of Selected Pure Compounds Isolated from Gut Bacteria of Animals Living in Polluted Environments |
| Q115658285 | Antibacterial Effects of Derivatives of Porphyrin, Naphthalene diimide, Aminophenol and Benzodioxane on Methicillin Resistant Staphylococcus aureus and Neuropathogenic Escherichia coli K1 |
| Q90633118 | Antibacterial Effects of Quinazolin-4(3H)-One Functionalized-Conjugated Silver Nanoparticles |
| Q94506907 | Anticancer Properties of Asian Water Monitor Lizard (Varanus salvator), Python (Malayopython reticulatus) and Tortoise (Cuora kamaroma amboinensis) |
| Q91573179 | Antidiabetic Drugs and Their Nanoconjugates Repurposed as Novel Antimicrobial Agents against Acanthamoeba castellanii |
| Q64093008 | Antimicrobial activities of green synthesized gums-stabilized nanoparticles loaded with flavonoids |
| Q90020897 | Antimicrobial discovery from natural and unusual sources |
| Q48200767 | Apoptosis in Acanthamoeba castellanii belonging to the T4 genotype. |
| Q92796882 | Aryl Quinazolinone Derivatives as Novel Therapeutic Agents against Brain-Eating Amoebae |
| Q35209525 | Atomic force microscopic imaging of Acanthamoeba castellanii and Balamuthia mandrillaris trophozoites and cysts |
| Q28251993 | Balamuthia amoebic encephalitis: an emerging disease with fatal consequences |
| Q41467455 | Balamuthia mandrillaris: Morphology, biology, and virulence |
| Q43274156 | Balamuthia mandrillaris: role of galactose in encystment and identification of potential inhibitory targets |
| Q42744176 | Balamuthia mandrillaris: staining properties of cysts and trophozoites and the effect of 2,6-dichlorobenzonitrile and calcofluor white on encystment |
| Q93118289 | Biologically active metabolite(s) from haemolymph of red-headed centipede Scolopendra subspinipes possess broad spectrum antibacterial activity |
| Q26851628 | Biology and pathogenesis of Acanthamoeba |
| Q38803807 | Biology and pathogenesis of Naegleria fowleri |
| Q42224262 | Black cobra (Naja naja karachiensis) lysates exhibit broad-spectrum antimicrobial activities |
| Q90194650 | Boron Nitride Doped Polyhydroxyalkanoate/Chitosan Nanocomposite for Antibacterial and Biological Applications |
| Q39238919 | Brain-Eating Amoebae: Predilection Sites in the Brain and Disease Outcome |
| Q47932685 | Brain-Eating Amoebae: Silver Nanoparticle Conjugation Enhanced Efficacy of Anti-Amoebic Drugs against Naegleria fowleri |
| Q92349998 | Brain-eating Amoebae Infection: Challenges and Opportunities in Chemotherapy |
| Q97548334 | Can the Environmental Phagocyte Acanthamoeba Be a Useful Model to Study SARS-CoV-2 Pathogenicity, Infectivity, and Evasion of Cellular Immune Defenses? |
| Q46039035 | Carbohydrate analysis of Acanthamoeba castellanii. |
| Q48308873 | Cellulose biosynthesis pathway is a potential target in the improved treatment of Acanthamoeba keratitis |
| Q28651985 | Cellulose degradation: a therapeutic strategy in the improved treatment of Acanthamoeba infections |
| Q94653952 | Centralized air-conditioning and transmission of novel coronavirus |
| Q57814687 | Clinically-approved drugs against CNS diseases as potential therapeutic agents to target brain-eating amoebae |
| Q64969114 | Cobalt nanoparticles as novel nanotherapeutics against Acanthamoeba castellanii. |
| Q63246683 | Cockroaches, locusts, and envenomating arthropods: a promising source of antimicrobials |
| Q47216509 | Combating Acanthamoeba spp. cysts: what are the options? |
| Q91961096 | Combination Therapy of Clinically Approved Antifungal Drugs Is Enhanced by Conjugation with Silver Nanoparticles |
| Q87669633 | Combined drug therapy in the management of granulomatous amoebic encephalitis due to Acanthamoeba spp., and Balamuthia mandrillaris |
| Q46305987 | Crocodiles and alligators: Antiamoebic and antitumor compounds of crocodiles |
| Q91724560 | Crocodiles and alligators: physicians' answer to cancer? |
| Q40796845 | Culturable Aerobic and Facultative Anaerobic Intestinal Bacterial Flora of Black Cobra (Naja naja karachiensis) in Southern Pakistan |
| Q98569532 | Current strategies to treat Acanthamoeba keratitis: a patent overview |
| Q98569531 | Current treatment options of Balamuthia mandrillaris: a patent overview |
| Q64326997 | Cytotoxic effects of Benzodioxane, Naphthalene diimide, Porphyrin and Acetamol derivatives on HeLa cells |
| Q48242116 | Cytotoxic effects of aflatoxin B1 on human brain microvascular endothelial cells of the blood-brain barrier. |
| Q54231808 | Development of nanoparticle-assisted PCR assay in the rapid detection of brain-eating amoebae. |
| Q42077824 | Dialectics of Imagination and Experimentation: Basic Science Research in Developing Countries |
| Q51528377 | Differential receptor dependencies: expression and significance of muscarinic M1 receptors in the biology of prostate cancer. |
| Q95831140 | Drug Discovery against Acanthamoeba Infections: Present Knowledge and Unmet Needs |
| Q40624360 | Effect of non-steroidal anti-inflammatory drugs on biological properties of Acanthamoeba castellanii belonging to the T4 genotype. |
| Q91445939 | Effects of Shape and Size of Cobalt Phosphate Nanoparticles against Acanthamoeba castellanii |
| Q38629265 | Escherichia coli K1 utilises host macropinocytic pathways for invasion of brain microvascular endothelial cells. |
| Q48433052 | Escherichia coli K1-induced cytopathogenicity of human brain microvascular endothelial cells |
| Q51187324 | Escherichia coli interactions with Acanthamoeba: a symbiosis with environmental and clinical implications. |
| Q41988958 | Eukaryotic cell encystation and cancer cell dormancy: is a greater devil veiled in the details of a lesser evil? |
| Q89724361 | Fabrication of biopolymer polyhydroxyalkanoate/chitosan and 2D molybdenum disulfide-doped scaffolds for antibacterial and biomedical applications |
| Q33850855 | Failure of chemotherapy in the first reported cases of Acanthamoeba keratitis in Pakistan. |
| Q47937479 | Future Priorities in Tackling Infections Due to Brain-Eating Amoebae. |
| Q92203551 | Galactose as novel target against Acanthamoeba cysts |
| Q44618777 | Genotypic, phenotypic, biochemical, physiological and pathogenicity-based categorisation of Acanthamoeba strains |
| Q35868588 | Gold Nanoparticle Conjugation Enhances the Antiacanthamoebic Effects of Chlorhexidine. |
| Q89391695 | Gold Nanoparticle-Conjugated Cinnamic Acid Exhibits Antiacanthamoebic and Antibacterial Properties |
| Q92980066 | Gold Nanoparticles Conjugation Enhances Antiacanthamoebic Properties of Nystatin, Fluconazole and Amphotericin B |
| Q96436213 | Gold-Conjugated Curcumin as a Novel Therapeutic Agent against Brain-Eating Amoebae |
| Q111319857 | Gut Bacteria of Rattus rattus (Rat) Produce Broad-Spectrum Antibacterial Lipopeptides |
| Q90284373 | Gut Bacteria of Water Monitor Lizard (Varanus salvator) Are a Potential Source of Antibacterial Compound(s) |
| Q91329690 | Gut bacteria of Cuora amboinensis (turtle) produce broad-spectrum antibacterial molecules |
| Q98184931 | Gut bacteria of Varanus salvator possess potential antitumour molecules |
| Q89986438 | Gut bacteria of animals living in polluted environments exhibit broad-spectrum antibacterial activities |
| Q92806704 | Gut bacteria of animals/pests living in polluted environments are a potential source of antibacterials |
| Q49861586 | Gut bacteria of cockroaches are a potential source of antibacterial compound(s). |
| Q97639383 | Gut microbiome and human health under the space environment |
| Q104584044 | Gut microbiota of animals living in polluted environments are a potential resource of anticancer molecules |
| Q97415662 | Heterometrus Spinifer: An Untapped Source of Anti-Tumor Molecules |
| Q98391710 | Homo sapiens versus SARS-CoV-2 |
| Q28182166 | Human immunodeficiency virus type 1 tat-mediated cytotoxicity of human brain microvascular endothelial cells |
| Q40506281 | Identification and characterization of antibacterial compound(s) of cockroaches (Periplaneta americana). |
| Q90434741 | Identification of antibacterial molecule(s) from animals living in polluted environments |
| Q95840372 | Immunity-Boosting Spices and the Novel Coronavirus |
| Q91162099 | Importance of Theranostics in Rare Brain-Eating Amoebae Infections |
| Q34344456 | In vitro efficacies of clinically available drugs against growth and viability of an Acanthamoeba castellanii keratitis isolate belonging to the T4 genotype |
| Q52649133 | In vitro inhibition of protease-activated receptors 1, 2 and 4 demonstrates that these receptors are not involved in an Acanthamoeba castellanii keratitis isolate-mediated disruption of the human brain microvascular endothelial cells. |
| Q53592481 | Inefficacy of marketed contact lens disinfection solutions against keratitis-causing Acanthamoeba castellanii belonging to the T4 genotype. |
| Q38995657 | Infection control strategy by killing drug-resistant bacteria |
| Q48271183 | Interactions of Pseudomonas aeruginosa and Corynebacterium spp. with non-phagocytic brain microvascular endothelial cells and phagocytic Acanthamoeba castellanii. |
| Q41221201 | Interactions of neuropathogenic Escherichia coli K1 (RS218) and its derivatives lacking genomic islands with phagocytic Acanthamoeba castellanii and nonphagocytic brain endothelial cells |
| Q99566935 | Irrigation System and COVID-19 Recurrence: A Potential Risk Factor in the Transmission of SARS-CoV-2 |
| Q49025040 | Is Acanthamoeba pathogenicity associated with intracellular bacteria? |
| Q42466969 | Is semen a useful diagnostic tool for rare infections of the central nervous system? |
| Q33360350 | Is there evidence of sexual reproduction (meiosis) in Acanthamoeba? |
| Q35982937 | Isolation of Balamuthia mandrillaris-specific antibody fragments from a bacteriophage antibody display library. |
| Q95929367 | Isoniazid Conjugated Magnetic Nanoparticles Loaded with Amphotericin B as a Potent Antiamoebic Agent against Acanthamoeba castellanii |
| Q51835962 | Killing the dead: chemotherapeutic strategies against free-living cyst-forming protists (Acanthamoeba sp. and Balamuthia mandrillaris). |
| Q48755593 | Laboratory testing of clinically approved drugs against Balamuthia mandrillaris. |
| Q90201741 | Leptospirosis: Increasing importance in developing countries |
| Q46531919 | Mechanisms associated with Acanthamoeba castellanii (T4) phagocytosis |
| Q95930296 | Metformin-coated silver nanoparticles exhibit anti-acanthamoebic activities against both trophozoite and cyst stages |
| Q97587847 | Metronidazole conjugated magnetic nanoparticles loaded with amphotericin B exhibited potent effects against pathogenic Acanthamoeba castellanii belonging to the T4 genotype |
| Q99547263 | Mycobacterium leprae: Pathogenesis, diagnosis, and treatment options |
| Q95834235 | Naegleria fowleri: differential genetic expression following treatment with Hesperidin conjugated with silver nanoparticles using RNA-Seq |
| Q40735334 | Neuropathogenic Escherichia coli K1 does not exhibit proteolytic activities to exert its pathogenicity |
| Q98880097 | Neuropathogens and Nasal Cleansing: Use of Clay Montmorillonite Coupled with Activated Carbon for Effective Eradication of Pathogenic Microbes from Water Supplies |
| Q92122093 | Novel Azoles as Antiparasitic Remedies against Brain-Eating Amoebae |
| Q56028054 | Novel Chemotherapeutic Strategies in the Management of Primary Amoebic Meningoencephalitis Due toNaegleria fowleri |
| Q92124105 | Novel Coronavirus: Current Understanding of Clinical Features, Diagnosis, Pathogenesis, and Treatment Options |
| Q92640284 | Novel antiacanthamoebic compounds belonging to quinazolinones |
| Q91284204 | Novel insights into the potential role of ion transport in sensory perception in Acanthamoeba |
| Q90867904 | Occurrence and molecular characterisation of Acanthamoeba isolated from recreational hot springs in Malaysia: evidence of pathogenic potential |
| Q91539216 | Occurrence of free-living amoebae (Acanthamoeba, Balamuthia, Naegleria) in water samples in Peninsular Malaysia |
| Q92198853 | Oleic Acid Coated Silver Nanoparticles Showed Better in Vitro Amoebicidal Effects against Naegleria fowleri than Amphotericin B |
| Q92059541 | Oleic acid-conjugated silver nanoparticles as efficient antiamoebic agent against Acanthamoeba castellanii |
| Q44490980 | Partial characterization of Acanthamoeba castellanii (T4 genotype) DNase activity |
| Q39044870 | Pathogenesis of microbial keratitis |
| Q41198501 | Photochemotherapeutic strategies against Acanthamoeba keratitis |
| Q38901985 | Photochemotherapeutic strategy against Acanthamoeba infections. |
| Q38186815 | Predator vs aliens: bacteria interactions with Acanthamoeba. |
| Q40169089 | Presence of rotavirus and free-living amoebae in the water supplies of Karachi, Pakistan. |
| Q50894077 | Prevalence of Acanthamoeba and superbugs in a clinical setting: coincidence or hyperparasitism? |
| Q21092270 | Primary amoebic meningoencephalitis caused by Naegleria fowleri: an old enemy presenting new challenges |
| Q56335462 | Primary amoebic meningoencephalitis: amoebicidal effects of clinically approved drugs against Naegleria fowleri |
| Q90380685 | Production of a monoclonal antibody against a mannose-binding protein of Acanthamoeba culbertsoni and its localization |
| Q95304526 | Proposed Intranasal Route for Drug Administration in the Management of Central Nervous System Manifestations of COVID-19 |
| Q90874080 | Pyrazinium thioacetate capped gold nanoparticles as Fe(III) sensor and Fe(III) marked anti-proliferating agent in human neuroblastoma cells |
| Q56267802 | Recommendations for the management of Acanthamoeba keratitis |
| Q90710173 | Repositioning of Guanabenz in Conjugation with Gold and Silver Nanoparticles against Pathogenic Amoebae Acanthamoeba castellanii and Naegleria fowleri |
| Q89774939 | Repurposing of Drugs Is a Viable Approach to Develop Therapeutic Strategies against Central Nervous System Related Pathogenic Amoebae |
| Q50890977 | Role of human tear fluid in Acanthamoeba interactions with the human corneal epithelial cells. |
| Q100380318 | SARS-CoV-2: Disinfection Strategies to Prevent Transmission of Neuropathogens via Air Conditioning Systems |
| Q98458348 | SARS-CoV-2: The Increasing Importance of Water Filtration against Highly Pathogenic Microbes |
| Q101044383 | Scorpion and Frog Organ Lysates are Potential Source of Antitumour Activity |
| Q90983498 | Sera/Organ Lysates of Selected Animals Living in Polluted Environments Exhibit Cytotoxicity against Cancer Cell Lines |
| Q85800042 | Silencing of xylose isomerase and cellulose synthase by siRNA inhibits encystation in Acanthamoeba castellanii |
| Q93178334 | Silver Nanoparticle Conjugation-Enhanced Antibacterial Efficacy of Clinically Approved Drugs Cephradine and Vildagliptin |
| Q47794406 | Silver nanoparticle conjugation affects antiacanthamoebic activities of amphotericin B, nystatin, and fluconazole. |
| Q46572072 | Size selectivity in antibiofilm activity of 3-(diphenylphosphino)propanoic acid coated gold nanomaterials against Gram-positive Staphylococcus aureus and Streptococcus mutans |
| Q92562173 | Special issue on Free Living Amoebae (FLA): Recent advances presented at the XVIIth International Meeting on the Biology and Pathogenicity of Free-Living Amoebae (FLAM, 2017), Zarzis, Tunisia |
| Q87352773 | Staphylococcus aureus exhibit similarities in their interactions with Acanthamoeba and ThP1 macrophage-like cells |
| Q50959685 | Status of free-living amoebae (Acanthamoeba spp., Naegleria fowleri, Balamuthia mandrillaris) in drinking water supplies in Karachi, Pakistan. |
| Q46305663 | Status of the effectiveness of contact lens disinfectants in Malaysia against keratitis-causing pathogens. |
| Q40093736 | Strategies to counter transmission of "superbugs" by targeting free-living amoebae. |
| Q28081584 | Stress management in cyst-forming free-living protists: programmed cell death and/or encystment |
| Q47697037 | Synthesis of 4-(dimethylamino)pyridine propylthioacetate coated gold nanoparticles and their antibacterial and photophysical activity. |
| Q90211106 | Synthetic Dihydropyridines as Novel Antiacanthamoebic Agents |
| Q99634212 | Synthetic nanoparticle-conjugated bisindoles and hydrazinyl arylthiazole as novel antiamoebic agents against brain-eating amoebae |
| Q38274893 | Tackling infection owing to brain-eating amoeba |
| Q40322348 | Targeting Brain-Eating Amoebae Infections. |
| Q96291297 | Targeting SARS-CoV-2: Novel Source of Antiviral Compound(s) against COVID-19? |
| Q50901654 | Targeting cyst wall is an effective strategy in improving the efficacy of marketed contact lens disinfecting solutions against Acanthamoeba castellanii cysts. |
| Q38947534 | The Development of Drugs against Acanthamoeba Infections. |
| Q91964640 | The Use of Nanomedicine for Targeted Therapy against Bacterial Infections |
| Q79421598 | The capsule plays an important role in Escherichia coli K1 interactions with Acanthamoeba |
| Q46123207 | The cyst wall carbohydrate composition of Balamuthia mandrillaris |
| Q50232285 | The effect of different environmental conditions on the encystation of Acanthamoeba castellanii belonging to the T4 genotype. |
| Q53550555 | The effect of environmental and physiological conditions on excystation of Acanthamoeba castellanii belonging to the T4 genotype. |
| Q43482253 | The effect of peptidic and non-peptidic proteasome inhibitors on the biological properties of Acanthamoeba castellanii belonging to the T4 genotype. |
| Q42593529 | The immortal amoeba: a useful model to study cellular differentiation processes? |
| Q100377937 | The increasing importance of the novel coronavirus |
| Q41432201 | The role of G protein coupled receptor-mediated signaling in the biological properties of Acanthamoeba castellanii of the T4 genotype. |
| Q42159562 | The role of Src kinase in the biology and pathogenesis of Acanthamoeba castellanii |
| Q40795267 | The role of genomic islands in Escherichia coli K1 interactions with intestinal and kidney epithelial cells. |
| Q54360638 | The type III secretion system is involved in Escherichia coli K1 interactions with Acanthamoeba. |
| Q50857094 | The use of dimethyl sulfoxide in contact lens disinfectants is a potential preventative strategy against contracting Acanthamoeba keratitis. |
| Q37986273 | War of the microbial worlds: who is the beneficiary in Acanthamoeba-bacterial interactions? |
| Q91850048 | War on Terror Cells: Strategies to Eradicate "Novel Coronavirus" Effectively |
| Q33850836 | War on terror cells: killing the host that harbours 'superbugs' is an infection control strategy in our fight against infectious diseases. |
| Q100511292 | hBN Nanoparticle-Assisted Rapid Thermal Cycling for the Detection of Acanthamoeba |
| Q93002998 | trans-Cinnamic Acid Conjugated Gold Nanoparticles as Potent Therapeutics against Brain-Eating Amoeba Naegleria fowleri |
Search more.